CAS 162857-78-5
:9H-Xanthène-9-one,2-(6-O-D-apio-b-D-furanosyl-b-D-glucopyranosyl)-1,3,6-trihydroxy-7-méthoxy-
- PolygalaxanthoneIII
2-((2S,3R,4R,5S,6R)-6-((((2R,3R,4R)-3,4-Dihydroxy-4-(hydroxymethyl)tetrahydrofuran-2-yl)oxy)methyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)-1,3,6-trihydroxy-7-methoxy-9H-xanthen-9-one
CAS :Formule :C25H28O15Degré de pureté :98%Masse moléculaire :568.4808polygalaxanthone III
CAS :Polygalaxanthone III can significantly inhibit chlorzoxazone 6-hydroxylation catalyzed by CYP2E1.Formule :C25H28O15Degré de pureté :99.09%Couleur et forme :SolidMasse moléculaire :568.48Polygalaxanthone III
CAS :Polygalaxanthone III can significantly inhibit chlorzoxazone 6-hydroxylation catalyzed by CYP2E1.Formule :C25H28O15Degré de pureté :95%~99%Masse moléculaire :568.484Polygalaxanthone iii
CAS :Natural glycosideFormule :C25H28O15Degré de pureté :≥ 95.0 % (HPLC)Couleur et forme :PowderMasse moléculaire :568.48Polygalaxanthone III
CAS :Polygalaxanthones III are natural polymers that can be found in the leaves of the plant Polygala tenuifolia. They have been shown to have apoptotic effects on cells, which may be due to their ability to increase mitochondrial membrane potential and inhibit mitochondrial functions. The polygalaxanthones also have a protective effect on human liver cells and can be used as an absorption enhancer. In addition, they are able to reduce inflammation by inhibiting NF-κB activation and suppressing the production of proinflammatory cytokines such as IL-1β, IL-6, TNFα, and IL-8. These polymers show good bioavailability when orally administered or injected into the body; however, their oral administration is not advised due to their low solubility in water. It is recommended that these compounds be administered intravenously or intramuscularly.
Formule :C25H28O15Degré de pureté :Min. 95%Couleur et forme :White PowderMasse moléculaire :568.48 g/mol






